AKT1 and renal cell carcinoma: Similarly, The CSCs markers CD133 and nanog expression were also inhibited upon the blocking of AKT/mTOR signals with inhibitors in co-cultured RCC 786-O (Figure 6D) and OSRC-2 cells (Figure 6E).